Redeye: Doro - Segment Reporting Highlights Value

Redeye continues to see very attractive risk/reward in the Doro stock. The company will be temporarily hit by the Corona crisis, but the balance sheet is strong. From 2021, we expect shares to be driven by an increased focus on the brand-new segment reporting that highlights the value of the Care segment.

Read more and download the research update: https://bit.ly/3eW1Cqk

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/